Filippatos G - Search Results

1

Anticoagulants, antiplatelets, and statins in heart failure.

Farmakis D, Filippatos G, Lainscak M, Parissis JT, Anker SD, Kremastinos DT. Farmakis D, et al. Among authors: filippatos g. Cardiol Clin. 2008 Feb;26(1):49-58, vi. doi: 10.1016/j.ccl.2007.10.001. Cardiol Clin. 2008. PMID: 18312905 Review.

2

Cytokines and anti-cytokine therapeutic approaches to chronic heart failure.

Parissis J, Filippatos G, Nikolaou V, Adamopoulos S. Parissis J, et al. Among authors: filippatos g. Eur J Intern Med. 2002 Sep;13(6):356. doi: 10.1016/s0953-6205(02)00092-4. Eur J Intern Med. 2002. PMID: 12225779

3

Chemokines in cardiovascular remodeling: clinical and therapeutic implications.

Filippatos G, Parissis JT, Adamopoulos S, Kardaras F. Filippatos G, et al. Curr Mol Med. 2003 Mar;3(2):139-47. doi: 10.2174/1566524033361546. Curr Mol Med. 2003. PMID: 12630560 Review.

4

Estrogen administration in patients with chronic heart failure: not ready for prime time.

Filippatos G, Parissis JT. Filippatos G, et al. Eur J Heart Fail. 2003 Mar;5(2):113-6. doi: 10.1016/s1388-9842(02)00255-6. Eur J Heart Fail. 2003. PMID: 12643999 Free article. No abstract available.

5

Studies on apoptosis and fibrosis in skeletal musculature: a comparison of heart failure patients with and without cardiac cachexia.

Filippatos GS, Kanatselos C, Manolatos DD, Vougas B, Sideris A, Kardara D, Anker SD, Kardaras F, Uhal B. Filippatos GS, et al. Int J Cardiol. 2003 Jul;90(1):107-13. doi: 10.1016/s0167-5273(02)00535-1. Int J Cardiol. 2003. PMID: 12821225

6

B-type natriuretic peptide serum levels in acute heart failure.

Filippatos GS, Anker SD, Kardaras F. Filippatos GS, et al. Eur Heart J. 2004 Jun;25(12):1085; author reply 1085-6. doi: 10.1016/j.ehj.2004.03.027. Eur Heart J. 2004. PMID: 15191781 No abstract available.

7

Pathophysiology of peripheral muscle wasting in cardiac cachexia.

Filippatos GS, Anker SD, Kremastinos DT. Filippatos GS, et al. Curr Opin Clin Nutr Metab Care. 2005 May;8(3):249-54. doi: 10.1097/01.mco.0000165002.08955.5b. Curr Opin Clin Nutr Metab Care. 2005. PMID: 15809526 Review.

8

Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failure.

Parissis JT, Panou F, Farmakis D, Adamopoulos S, Filippatos G, Paraskevaidis I, Venetsanou K, Lekakis J, Kremastinos DT. Parissis JT, et al. Among authors: filippatos g. Am J Cardiol. 2005 Aug 1;96(3):423-6. doi: 10.1016/j.amjcard.2005.03.092. Am J Cardiol. 2005. PMID: 16054474 Clinical Trial.

9

Levosimendan for the treatment of acute heart failure syndromes.

Parissis JT, Filippatos G, Farmakis D, Adamopoulos S, Paraskevaidis I, Kremastinos D. Parissis JT, et al. Among authors: filippatos g. Expert Opin Pharmacother. 2005 Dec;6(15):2741-51. doi: 10.1517/14656566.6.15.2741. Expert Opin Pharmacother. 2005. PMID: 16316312 Review.

10

Management with a pulmonary artery catheter did not reduce all-cause mortality in critically ill patients.

Filippatos GS, Schünemann H, Kremastinos DT. Filippatos GS, et al. ACP J Club. 2006 Jan-Feb;144(1):21. ACP J Club. 2006. PMID: 16388570 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

923 results

Search Page

Filters